AI assistant
Sending…
ATAI Life Sciences N.V. — Director's Dealing 2021
Jun 24, 2021
32049_dirs_2021-06-24_45ec7958-ae2f-4e42-a7d0-b0647c7b903f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ATAI Life Sciences N.V. (ATAI)
CIK: 0001840904
Period of Report: 2021-06-22
Reporting Person: Auerbach Michael (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-22 | Common Shares | P | 4666 | $15.00 | Acquired | 5564474 | Indirect |
Footnotes
F1: Mr. Auerbach serves as General Partner of Subversive ATAI LLC, a multi-member limited liability company. Mr. Auerbach has sole voting and investment power with respect to the shares held by Subversive ATAI LLC.
More from ATAI Life Sciences N.V.
Regulatory Filings
2026
Mar 20
Regulatory Filings
2025
Dec 30
Regulatory Filings
2025
Dec 30
Regulatory Filings
2025
Dec 30
Regulatory Filings
2025
Dec 5
Capital/Financing Update
2025
Dec 5
Director's Dealing
2025
Nov 26
Interim / Quarterly Report
2025
Nov 12
Earnings Release
2025
Nov 12
Director's Dealing
2025
Nov 7